Phytochemicals of Aloe barbadensis miller as Potential Inhibitors of Uropathogenic Escherichia coli for Urinary Tract Infection Therapy: An in Silico Approach
Urinary tract infections (UTIs) are common infections caused by normal skin or rectum bacteria that get into the urethra and infect the urinary tract. Although the infection can affect various parts of the tract, bladder infections are the most prevalent kind. Uropathogenic Escherichia Coli (UPEC) is the most common pathogen associated with UTI development. Therefore, inhibiting the UPEC protein target (PDB ID: 8BVD) appears to be a promising therapeutic strategy. Therefore, in this study, molecular docking and dynamics were conducted to examine the antibacterial activity of Aloe barbadensis miller against UPEC bacteria. The Aloe barbadensis miller natural compounds licochalcone A, palmidin B and palmidin C were downloaded from PubChem with amoxicillin, which was used as a control drug and studied against the target molecule. The potential parameters examined were the docking scores, absorption, distribution, metabolism, excretion, toxicity (ADMET), bioavailability, root mean square deviation (RMSD), root mean square fluctuation (RMSF), hydrogen bonding, radius of gyration, and potential energy of the system. Docking scores showed that all ligands demonstrated an admirable candidature as an inhibitor to 8BVD molecule, and the score hierarchy is licochalcone A (-6.4 kcal/mol), palmidin C (-6.1 kcal/mol), palmidin B (-6.0 kcal/mol), and amoxicillin (-5.9 kcal/mol). All ligands appeared to have good drug-like properties and oral bioavailability. Molecular dynamic studies showed that all ligands exhibited an excellent nominee as inhibitors in their vicinity at 20 ns. However, there is a relatively high fluctuation of palmidin B compared with other compounds, which seems to be more stable. This work suggests that the selected phytoconstituents could be used as inhibitors of the 8BVD protein in the fight against UTIs. However, further investigation on the clinical and experimental validation of UTI treatment’s specific mechanisms and effects is still welcomed.
References
[1]
Indu, S., Surajit, C. and Sagolsem, Y. (2021) In Silico Screening of Some Phytochemicals for Treating Urinary Tract Infection (UTI) Targeting fimH Gene. African Journal of Bioscience, 3, 157-164. https://ssrn.com/abstract=3772355 https://doi.org/10.33472/AFJBS.3.1.2021.157-164
[2]
Arsene, M.M.J., Viktorovna, P.I., Sergei, G.V., Hajjar, F., Vyacheslavovna, Y.N., Vladimirovna, Z.A., Aleksandrovna, V.E., Nikolayevich, S.A. and Sachivkina, N. (2022) Phytochemical Analysis, Antibacterial and Antibiofilm Activities of Aloe vera Aqueous Extract against Selected Resistant Gram-Negative Bacteria Involved in Urinary Tract Infections. Fermentation, 8, Article 626. https://doi.org/10.3390/fermentation8110626
[3]
Jagdish, R. and Nehra, K. (2022) Bryophyllumpinnatum Mediated Synthesis of Zinc Oxide Nanoparticles: Characterization and Application as Biocontrol Agents for Multi-Drug-Resistant Uropathogens. Heliyon, 8, E11080. https://doi.org/10.1016/j.heliyon.2022.e11080
[4]
Khoshkbejari, M., Jafari, A. and Safari, M. (2015) Ag/ZnO Nanoparticles as Novel Antibacterialagent against of Escherichia Coli Infection, in Vitro & in Vivo. Oriental Journal of Chemistry, 31, 1437-1445. https://doi.org/10.13005/ojc/310322
[5]
Flores-Mireles, A.L., Walker, J.N., Caparon, M. and Hultgren, S.J. (2015) Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options. Nature Reviews Microbiology, 13, 269-284. https://doi.org/10.1038/nrmicro3432
[6]
Zagaglia, C., Ammendolia, M.G., Maurizi, L., Nicoletti, M. and Longhi, C. (2022) Urinary Tract Infections Caused by Uropathogenic Escherichia coli Strains—New Strategies for an Old Pathogen. Microorganisms, 10, Article 1425. https://doi.org/10.3390/microorganisms10071425
[7]
Storme, O., Tirán Saucedo, J., Garcia-Mora, A., Dehesa-Dávila, M. and Naber, K.G. (2019) Risk Factors and Predisposing Conditions for Urinary Tract Infection. Therapeutic Advances in Urology, 11, 19-28. https://doi.org/10.1177/1756287218814382
[8]
Jaiswal, S.K., Sharma, N.K., Bharti, S.K., Krishnan, S., Kumar, A., Prakash, O., Kumar, P., Kumar, A. and Gupta, A.K. (2018) Phytochemicals as Uropathognic Escherichia Coli FimH Antagonist: In Vitro and in Silico Approach. Current Molecular Medicine, 18, 640-653. https://doi.org/10.2174/1566524019666190104104507
[9]
Derakhshandeh, A., Firouzi, R., Motamedifar, M., Motamedi Boroojeni, A., Bahadori, M., Arabshahi, S., Novinrooz, A. and Heidari, S. (2015) Distribution of Virulence Genes and Multiple Drug-Resistant Patterns amongst Different Phylogenetic Groups of Uropathogenic Escherichia coli Isolated from Patients with Urinary Tract Infection. Letters in Applied Microbiology, 60, 148-154. https://doi.org/10.1111/lam.12349
[10]
Hojati, Z., Zamanzad, B., Hashemzadeh, M., Molaie, R. and Gholipour, A. (2015) Detection of FimH Gene in Uropathogenic Escherichia coli Strains Isolated from Patients with Urinary Tract Infection. Journal of Microbiology, 8, e17520. https://doi.org/10.5812/jjm.17520
[11]
Shah, C., Baral, R., Bartaula, B. and Shrestha, L.B. (2019) Virulence Factors of Uropathogenic Escherichia coli (UPEC) and Correlation with Antimicrobial Resistance. BMC Microbiology, 19, Article No. 204. https://doi.org/10.1186/s12866-019-1587-3
[12]
Gupta, K., Hooton, T.M., Naber, K.G., Wullt, B., Colgan, R., Miller, L.G., Moran, G.J., Nicolle, L.E., Raz, R., Schaeffer, A.J. and Soper, D.E. (2011) International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases, 52, e103-e120. https://doi.org/10.1093/cid/ciq257
[13]
Stanton, I.C., Bethel, A., Leonard, A.F.C., Gaze, W.H. and Garside, R. (2020) What Is the Research Evidence for Antibiotic Resistance Exposure and Transmission to Humans from the Environment? A Systematic Map Protocol. Environmental Evidence, 9, Article No. 12. https://doi.org/10.1186/s13750-020-00197-6
[14]
Warren, J.W., Abrutyn, E., Hebel, J.R., Johnson, J.R., Schaeffer, A.J. and Stamm, W.E. (1999) Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women. Clinical Infectious Diseases, 29, 745-759. https://doi.org/10.1086/520427
[15]
Bathaie, S.Z., Faridi, N., Nasimian, A., Heidarzadeh, H. and Tamanoi, F. (2015) How Phytochemicals Prevent Chemical Carcinogens and/or Suppress Tumor Growth? The Enzymes, 37, 1-42. https://doi.org/10.1016/bs.enz.2015.06.003
[16]
Fatriansyah, J.F., Rizqillah, R.K., Yandi, M.Y. and Muhamad Sahlan, F. (2022) Molecular Docking and Dynamics Studies on Propolis Sulabiroin-A as a Potential Inhibitor of SARS-CoV-2. Journal of King Saud University—Science, 34, Article ID: 101707. https://doi.org/10.1016/j.jksus.2021.101707
[17]
Yu, W. and MacKerell Jr., A.D. (2017) Computer-Aided Drug Design Methods. In: Sass, P., Ed., Antibiotics, Humana Press, New York, 85-106. https://doi.org/10.1007/978-1-4939-6634-9_5
[18]
Preman, G., Mulani, M., Bare, A., Relan, K., Sayyed, L., Jha, V. and Pandey, K. (2022) Virtual Screening of Phytochemicals for Anti-Tubercular Potential Using Molecular Docking Approach. Journal of Tuberculosis, 5, 1030.
[19]
Sliwoski, G., Kothiwale, S., Meiler, J. and Lowe Jr., E.W. (2013) Computational Methods in Drug Discovery. Pharmacological Reviews, 66, 334-395. https://doi.org/10.1124/pr.112.007336
[20]
Bittner Fialová, S., Rendeková, K., Mučaji, P., Nagy, M. and Slobodníková, L. (2021) Antibacterial Activity of Medicinal Plants and Their Constituents in the Context of Skin and Wound Infections, Considering European Legislation and Folk Medicine—A Review. International Journal of Molecular Sciences, 22, Article 10746. https://doi.org/10.3390/ijms221910746
[21]
Goudarzi, M., Ghafari, S., Navidinia, M. and Azimi, H. (2018) Aloe vera Gel: Effective Therapeutic Agent against Extended-Spectrum β-Lactamase Producing Escherichia coli Isolated from Patients with Urinary Tract Infection in Tehran-Iran. Journal of Pure and Applied Microbiology, 11, 1401-1408. https://doi.org/10.22207/JPAM.11.3.22
[22]
Newman, D.J. and Cragg, G.M. (2020) Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural Products, 83, 770-803. https://doi.org/10.1021/acs.jnatprod.9b01285
[23]
Mousavifar, L., Sarshar, M., Bridot, C., Scribano, D., Ambrosi, C., Palamara, A.T., Vergoten, G., Roubinet, B., Landemarre, L., Bouckaert, J. and René, R. (2023) Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics, 15, Article 527. https://doi.org/10.3390/pharmaceutics15020527
[24]
Liebschner, D., Afonine, P.V., Baker, M.L., Bunkóczi, G., Chen, V.B., Croll, T.I., Hintze, B., Hung, L.W., Jain, S., McCoy, A.J., et al. (2019) Macromolecular Structure Determination Using X-Rays, Neutrons and Electrons: Recent Developments in Phenix. Acta Crystallographica, D75, 861-877. https://doi.org/10.1107/S2059798319011471
[25]
Kleywegt, G.J. and Jones, T.A. (1997) Model Building and Refinement Practice. Methods in Enzymology, 277, 208-230. https://doi.org/10.1016/S0076-6879(97)77013-7
[26]
Abe, C.M., Salvador, A., Falsetti, I.N., Blanco, E. and Blanco, M. (2008) Uropathogenic Escherichia coli (UPEC) Strains May Carry Virulence Properties of Diarrhoeagenic E. coli. FEMS Immunology & Medical Microbiology, 52, 397-406. https://doi.org/10.1111/j.1574-695X.2008.00388.x
[27]
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C. and Ferrin, T.E. (2004) UCSF Chimera—A Visualization System for Exploratory Research and Analysis. Journal of Computational Chemistry, 25, 1605-1612. https://doi.org/10.1002/jcc.20084
[28]
Huang, C.C., Couch, G.S., Pettersen, E.F. and Chimera, F.T.E. (1996) An Extensible Molecular Modeling Application Constructed Using Standard Components. Pacific Symposium on Biocomputing, 1, Article 724.
[29]
Zafar, F., Gupta, A., Thangavel, K., Khatana, K., Sani, A.A., Ghosal, A., Tandon, P. and Nishat, N. (2020) Physicochemical and Pharmacokinetic Analysis of Anacardic Acid Derivatives. ACS Omega, 5, 6021-6030. https://doi.org/10.1021/acsomega.9b04398
[30]
Camp, D., Garavelas, A. and Campitelli, M. (2015) Analysis of Physicochemical Properties for Drugs of Natural Origin. Journal of Natural Products, 78, 1370-1382. https://doi.org/10.1021/acs.jnatprod.5b00255
[31]
Honório, K.M., Moda, T.L. and Andricopulo, A.D. (2013) Pharmacokinetic Properties and in Silico ADME Modeling in Drug Discovery. Medicinal Chemistry, 9, 163-176. https://doi.org/10.2174/1573406411309020002
[32]
Jia, C.Y., Li, J.Y., Hao, G.F. and Yang, G.F. (2020) A Drug-Likeness Toolbox Facilitates ADMET Study in Drug Discovery. Drug Discovery Today, 25, 248-258. https://doi.org/10.1016/j.drudis.2019.10.014
[33]
Pires, D.E.V., Blundell, T.L. and Ascher, D.B. (2015) Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of Medicinal Chemistry, 58, 4066-4072. https://doi.org/10.1021/acs.jmedchem.5b00104
[34]
Oomariyah, N. and van Dijk, G. (2022) The Bioavailability Prediction and Screening Phytochemicals of Sansevieria Trifasciata Leaves Extract. MATEC Web of Conferences, 372, Article ID: 02003. https://doi.org/10.1051/matecconf/202237202003
[35]
Udugade, S.B., Doijad, R.C. and Udugade, B.V. (2019) In Silico Evaluation of Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Momordicin1: An Active Chemical Constituent of Momordica Charantia. Journal of Advanced Scientific Research, 10, 222-229.
Hansson, T., Oostenbrink, C. and van Gunsteren, W. (2002) Molecular Dynamics Simulations. Current Opinion in Structural Biology, 12, 190-196. https://doi.org/10.1016/S0959-440X(02)00308-1
[38]
Hess, B., Kutzner, C., Van Der Spoel, D. and Lindahl, E. (2008) GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. Journal of Chemical Theory and Computation, 4, 435-447. https://doi.org/10.1021/ct700301q
[39]
Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A.E. and Berendsen, H.J. (2005) GROMACS: Fast, Flexible, and Free. Journal of Computational Chemistry, 26, 1701-1718. https://doi.org/10.1002/jcc.20291
[40]
Salaria, D., Rolta, R., Mehta, J., Awofisayo, O., Fadare, O.A., Kaur, B., Kumar, B., Araujo da Costa, R., Chandel, S.R., Kaushik, N., Choi, E.H. and Kaushik, N.K. (2022) Phytoconstituents of Traditional Himalayan Herbs as Potential Inhibitors of Human Papillomavirus (HPV-18) for Cervical Cancer Treatment: An in Silico Approach. PLOS ONE, 17, e0265420. https://doi.org/10.1371/journal.pone.0265420
[41]
Galande, A.K. and Rohane, S.H. (2021) Insilico Molecular Docking Analysis in Maestro Software. Asian Journal of Research in Chemistry, 14, 97-100. https://doi.org/10.5958/0974-4150.2021.00017.1
[42]
Olloquequi, J., Ettcheto, M., Cano, A., Fortuna, A., Bicker, J., Sánchez-Lopez, E., Paz, C., Ureña, J., Verdaguer, E., Auladell, C., et al. (2023) Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences, 24, Article 14177. https://doi.org/10.3390/ijms241814177
[43]
Li, M.T., Xie, L., Jiang, H.M., Huang, Q., Tong, R.S., Li, X., Xie, X. and Liu, H.M. (2022) Role of Licochalcone a in Potential Pharmacological Therapy: A Review. Frontiers in Pharmacology, 13, Article 878776. https://doi.org/10.3389/fphar.2022.878776
[44]
Madeddu, F., Di Martino, J., Pieroni, M., Del Buono, D., Bottoni, P., Botta, L., Castrignanò, T. and Saladino, R. (2022) Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of New Drugs against Human Topoisomerase I Receptor. International Journal of Molecular Sciences, 23, Article 14652. https://doi.org/10.3390/ijms232314652
[45]
Hu, Q., Feng, M., Lai, L. and Pei, J. (2018) Prediction of Drug-Likeness Using Deep Autoencoder Neural Networks. Frontiers in Genetics, 9, Article 422486. https://doi.org/10.3389/fgene.2018.00585
[46]
Lin, J.H., Yang, K.T., Ting, P.C., Lee, W.S., Lin, D.J. and Chang, J.C. (2023) Licochalcone a Improves Cardiac Functions after Ischemia-Reperfusion via Reduction of Ferroptosis in Rats. European Journal of Pharmacology, 957, Article ID: 176031. https://doi.org/10.1016/j.ejphar.2023.176031
[47]
Daniyal, M., Mahmood Tahir, I., Akram, M., Zahid, R., Zainab, R., Riaz, Z., Laila, U., Riaz, T., Wang, W. and Bin, L. (2019) Pharmacological Effects of Rheum Emodi: A Multiple Purpose Plant in Health and Disease. Journal of Medical and Biological Sciences, 2, 68-73.
[48]
Rao, P., Shukla, A., Parmar, P., Rawal, R.M., Patel, B., Saraf, M. and Goswami, D. (2020) Reckoning a Fungal Metabolite, Pyranonigrin A as a Potential Main Protease (Mpro) Inhibitor of Novel SARS-CoV-2 Virus Identified Using Docking and Molecular Dynamics Simulation. Biophysical Chemistry, 264, Article ID: 106425. https://doi.org/10.1016/j.bpc.2020.106425
[49]
Ndombera, F.T., Maiyoh, G.K.K. and Tuei, V.C. (2019) Pharmacokinetic, Physicochemical and Medicinal Properties of N-Glycoside Anti-Cancer Agent More Potent than 2-Deoxy-D-Glucose in Lung Cancer Cells. Journal of Pharmacy and Pharmacology, 7, 165-176. https://doi.org/10.17265/2328-2150/2019.04.003
[50]
Daina, A., Michielin, O. and Zoete, V. (2017) SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Scientific Reports, 7, Article No. 42717. https://doi.org/10.1038/srep42717
[51]
Hansson, T., Oostenbrink, C. and van Gunsteren, W.F. (2002) Molecular Dynamics Simulations. Current Opinion in Structural Biology, 12, 190-196. https://doi.org/10.1016/S0959-440X(02)00308-1
[52]
Anwer, K., Sonani, R., Madamwar, D., Singh, P., Khan, F., Bisetty, K., Ahmad, F. and Hassan, M.I. (2015) Role of N-Terminal Residues on Folding and Stability of C-Phycoerythrin: Simulation and Urea-Induced Denaturation Studies. Journal of Biomolecular Structure and Dynamics, 33, 121-133. https://doi.org/10.1080/07391102.2013.855144
[53]
GROMACS Tutorial: Coarse-Grained Simulation of a Protein Membrane System. https://www.compchems.com/hydrogen-bond-analysis-with-vmd/#step-6-analyzing-the-results
[54]
Mohammad, T., Siddiqui, S., Shamsi, A., Alajmi, M.F., Hussain, A., Islam, A., Ahmad, F. and Hassan, M.I. (2020) Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies. Molecules, 25, Article 823. https://doi.org/10.3390/molecules25040823
[55]
Anusuya, S., Velmurugan, D. and Gromiha, M.M. (2015) Identification of Dengue Viral RNA-Dependent RNA Polymerase Inhibitor Using Computational Fragment Based Approaches and Molecular Dynamics Study. Journal of Biomolecular Structure and Dynamics, 34, 1512-1532. https://doi.org/10.1080/07391102.2015.1081620
[56]
Martínez, L. (2015) Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis. PLOS ONE, 10, e0119264. https://doi.org/10.1371/journal.pone.0119264
[57]
Lobanov, M.Y., Bogatyreva, N.S. and Galzitskaya, O.V. (2008) Radius of Gyration as an Indicator of Protein Structure Compactness. Molecular Biology, 42, 623-628. https://doi.org/10.1134/S0026893308040195
[58]
Lakshmi, S.A., Shafreen, R.M.B., Priya, A. and Shunmugiah, K.P. (2021) Ethnomedicines of Indian Origin for Combating COVID-19 Infection by Hampering the Viral Replication: Using Structure-Based Drug Discovery Approach. Journal of Biomolecular Structure and Dynamics, 39, 4594-4609. https://doi.org/10.1080/07391102.2020.1778537
[59]
Veeresham, C. (2012) Natural Products Derived from Plants as a Source of Drugs. Journal of Advanced Pharmaceutical Technology & Research, 3, 200-201. https://doi.org/10.4103/2231-4040.104709
